周四盘中，眼科医疗设备公司Glaukos Corp（股票代码：GKOS）股价出现大幅下跌，截至盘中跌幅达5.03%。这一显著跌幅引起了市场的关注。
造成Glaukos股价下跌的原因可能与多家知名投资银行对该公司的最新评级调整有关。摩根大通将Glaukos的目标价从100美元上调至110美元，而Truist Securities则将目标价从130美元下调至126美元。此外，瑞穗证券也将Glaukos的目标价从150美元下调至130美元，富国银行则将目标价从86美元上调至92美元。
这些不同方向的目标价调整反映了分析师对Glaukos未来前景看法的分歧。尽管部分机构上调了目标价，但下调目标价的举动可能引发了投资者对公司增长前景的担忧，从而导致股价下跌。市场将继续关注Glaukos的后续表现，以及公司能否通过强劲的业绩来重新赢得投资者的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.